November is Lung Cancer Awareness Month, a critical time to highlight the <a href="https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834#" target="_blank" rel="noreferrer noopener">world&#8217;s most deadly</a> form of cancer. Unfortunately, research into this devastating disease remains significantly underfunded. At the 23andMe Research Institute, we are committed to raising awareness and changing the nature of research into this disease. In <a href="https://blog.23andme.com/articles/23andme-launches-new-genetic-study-of-lung-cancer" target="_blank" rel="noreferrer noopener">July 2024</a>, 23andMe, Troper Wojcicki Philanthropies, and 20 patient and research advocacy organizations launched the <a href="https://www.23andme.com/lung-cancer/" target="_blank" rel="noreferrer noopener">Lung Cancer Genetics Study</a>. Overseen by scientific and patient advisory boards, the goal is to enroll 10,000 individuals who have been diagnosed with lung cancer to help build a comprehensive genetics research database that captures the diversity of people impacted by the disease.&nbsp;



This mission is a personal one, championed by the late Susan Wojcicki, former YouTube CEO and sister of Anne Wojcicki, the founder and CEO of the 23andMe Research Institute. After her own diagnosis, Susan dedicated herself to <a href="https://blog.23andme.com/articles/a-legacy-of-hope-in-the-fight-against-lung-cancer" target="_blank" rel="noreferrer noopener">advocating for more research and awareness</a> to improve outcomes for all patients. Her legacy and vision are at the heart of these efforts.



<h2 class="wp-block-heading" id="h-more-about-lung-cancer">More About Lung Cancer</h2>



Lung cancer kills more people each year in the United States than <a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf" target="_blank" rel="noreferrer noopener">colon, breast, and prostate cancer combined</a>. On top of the challenge of a cancer diagnosis, a lung cancer diagnosis often comes with the additional challenge of the myth that lung cancer affects only those with a history of tobacco use. This misconception often leads to a <a href="https://go2.org/lung-cancer-stigma/" target="_blank" rel="noreferrer noopener">harmful stigma</a>, unfairly suggesting that individuals somehow deserve the disease or brought it upon themselves. However, the truth is that anyone with lungs can get lung cancer, and no one deserves it.



While exposure to tobacco smoke is an important and well-studied risk factor for lung cancer, <a href="https://www.cancer.org/cancer/types/lung-cancer/causes-risks-prevention/what-causes.html" target="_blank" rel="noreferrer noopener">many other factors</a>—such as genetics, other health conditions, or exposure to harmful substances like air pollution or radon gas—can also play a role. In fact, <a href="https://www.cdc.gov/lung-cancer/nonsmokers/index.html" target="_blank" rel="noreferrer noopener">10–20 percent </a>of people who develop lung cancers have never smoked or smoked less than 100 cigarettes in their lifetime. Conversely, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2409903/" target="_blank" rel="noreferrer noopener">80–90 percent</a> of people with a history of tobacco exposure never get the disease. The causes of lung cancer are complex, and much research is still needed to understand how different risk factors interact and why some people get lung cancer while others do not. Breaking down this stigma is critical to building awareness, driving progress, and increasing research and funding into this deadly disease.



<h2 class="wp-block-heading" id="h-the-lung-cancer-genetics-study">The Lung Cancer Genetics Study</h2>



In its first year alone, the Lung Cancer Genetics Study has enrolled over 1,200 participants. By studying their genetic data alongside survey responses about their experience, medical history, and lifestyle, we aim to transform the scientific understanding of this disease.



This research aims to help:



<ul class="wp-block-list">
<li>Identify risk factors for lung cancer.</li>



<li>Improve methods for early detection and screening.</li>



<li>Better identify individuals who are at high risk.</li>



<li>Advance the development of new, personalized, and targeted treatments.</li>
</ul>



One of the first questions this study is asking is how can someone’s genetics and what they’re exposed to in their environment interact to impact their risk of lung cancer. Early data addressing this question was presented at the <a href="https://wclc.iaslc.org/" target="_blank" rel="noreferrer noopener">IASLC 2025 World Conference on Lung Cancer</a>. For this analysis, 23andMe researchers explored whether a set of rare, genetic variants might impact lung cancer risk differently in people who have smoked compared to people who haven’t smoked. To do this, they examined data from 1010 individuals with lung cancer and asked whether the rare genetic variants were more common in people with or without a history of active tobacco exposure.&nbsp;



The researchers found <a href="https://www.sciencedirect.com/science/article/abs/pii/S1556086425022518" target="_blank" rel="noreferrer noopener">no correlation</a> between the presence of these rare genetic variants and smoking history in these individuals. But research like this often requires large numbers of research participants, so as the Lung Cancer Genetics Study grows and joins forces with other studies, researchers can reassess and continue to look for genetic variants that may influence the development of lung cancer and learn even more about how genetics and the environment impact lung cancer risk.



<h2 class="wp-block-heading" id="h-collaboration-and-data-sharing">Collaboration and Data-Sharing</h2>



A key part of this initiative is building powerful new tools to break down research silos. In collaboration with Troper Wojcicki Philanthropies and Lifebit, the 23andMe Research Institute introduced <a href="https://blog.23andme.com/articles/powerful-new-tool-opens-lung-cancer-data-for-research-breakthroughs" target="_blank" rel="noreferrer noopener">a secure, open-source data platform</a> for researchers to access the data from the Lung Cancer Genetics Study. This platform provides qualified researchers with no-cost access to genetic data and self-reported clinical, lifestyle, and tumor biomarker data from consented research participants, empowering the global scientific community to fast-track new discoveries. Importantly, patients will participate in the data governance process by reviewing and giving feedback on proposed research projects to ensure the work stays grounded in what matters most.



<h2 class="wp-block-heading" id="h-how-you-can-get-involved">How You Can Get Involved</h2>



This critical research is only possible through the participation of those directly affected by lung cancer. By participating, those who have been diagnosed with lung cancer can help build the knowledge base needed to unlock new breakthroughs for future generations.



To learn more about the Lung Cancer Genetics Study, our collaborators, and the eligibility criteria, please visit<a href="https://www.23andme.com/lung-cancer/" target="_blank" rel="noreferrer noopener"> 23andme.com/lung-cancer</a>.

Uniting for a Cure: A Look at 23andMe’s Lung Cancer Research

<h5 class="wp-block-heading" id="h-data-initiative-accelerates-access-to-vital-genetic-and-clinical-insights">Data initiative accelerates access to vital genetic and clinical insights</h5>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1200" height="675" src="http://35.88.189.111/wp-content/uploads/2025/09/lung-double-edited-2.png" alt="Illustration of lungs on a background with a larger illustration of lungs" class="wp-image-34192" srcset="https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2.png 1200w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2-300x169.png 300w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2-1024x576.png 1024w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2-768x432.png 768w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2-880x495.png 880w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/lung-double-edited-2-1180x664.png 1180w" sizes="auto, (max-width: 1200px) 100vw, 1200px" /></figure>



At the 2025 World Conference on Lung Cancer in Barcelona, the 23andMe Research Institute, in collaboration with Troper Wojcicki Philanthropies and the health data software company Lifebit, introduced an open-source platform that could help fast-track research discoveries through a powerful new cancer data repository.



The announcement comes just a year after the start of the<a href="https://www.23andme.com/lung-cancer" target="_blank" rel="noreferrer noopener"> Lung Cancer Genetics Study</a>, spearheaded by 23andMe and bringing together more than 20 lung cancer advocacy and science organizations to recruit 10,000 people diagnosed with lung cancer. Their goal is to develop new ways to identify those at highest risk for lung cancer early, while also finding possible new treatments for this deadly cancer.



<h2 class="wp-block-heading">The Personal Drive Behind the Mission</h2>



The effort is personal for many of the advocates who are part of the collaboration and also for Anne Wojcicki, founder and CEO of the 23andMe Research Institute. Anne&#8217;s sister Susan Wojcicki died of lung cancer last year, just as the study began.



&#8220;My sister was passionate about understanding the science behind lung cancer so future generations could prevent the disease and treat it. The Lung Cancer Genetics Study is a step towards achieving that.” Anne said.



In the months before her death, <a href="https://blog.23andme.com/articles/a-legacy-of-hope-in-the-fight-against-lung-cancer" target="_blank" rel="noreferrer noopener">Susan had been very involved in helping to create the study with the hope that it could help others</a>. The idea was not just to leverage genetic data for insights into lung cancer but also to create a repository of data that would be available to as many qualified researchers as possible.&nbsp;



The platform — created through the collaboration between the 23andMe Research Institute, Troper Wojcicki Philanthropies, and Lifebit — offers a secure, open-source data platform for researchers to access this novel dataset. Powered by Lifebit&#8217;s Health Data Ecosystem, the platform provides qualified researchers with no-cost access to de-identified data from people diagnosed with lung cancer who have consented to participate in this research.&nbsp;



&#8220;More people die of lung cancer each year than breast, colon, and prostate cancer combined, yet it is one of the least funded for research. It’s important for this powerful new tool to be available at no cost to qualified researchers so that the best minds can work on unlocking the genetic insights that may lead to a cure,&#8221; said Anne.



<h2 class="wp-block-heading">Building a One-of-a-Kind Data Resource</h2>



Since launching the <a href="https://blog.23andme.com/articles/23andme-launches-new-genetic-study-of-lung-cancer" target="_blank" rel="noreferrer noopener">Lung Cancer Genetics Study</a>, more than 1,200 people diagnosed with lung cancer have enrolled to participate in the research. The goal is to enroll 10,000 people by 2027, but the study has already assembled one of the most diverse cohorts ever for lung cancer genetic research.&nbsp;



<figure class="wp-block-image alignright size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="464" src="http://35.88.189.111/wp-content/uploads/2025/09/teal_waldos-1024x464.jpg" alt="" class="wp-image-34183" style="width:242px;height:auto" srcset="https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/teal_waldos-1024x464.jpg 1024w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/teal_waldos-300x136.jpg 300w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/teal_waldos-768x348.jpg 768w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/teal_waldos-880x399.jpg 880w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2025/09/teal_waldos-1180x534.jpg 1180w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>



Genetics is just one of many factors involved in why some people develop lung cancer. Exposure to tobacco smoke is perhaps the best-known risk factor; however, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2409903/" target="_blank" rel="noreferrer noopener">80 to 90%</a> of people with a history of tobacco exposure never get lung cancer, and many people without tobacco exposure get the disease. These facts underscore the importance of investigating other, less well-known risk factors, like air pollution, radon exposure, and workplace-related exposures.



And there&#8217;s much more we don&#8217;t know about lung cancer. Many do not realize, for instance, that lung cancer is the <a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf" target="_blank" rel="noreferrer noopener">number one cause of cancer death in women</a> and <a href="https://www.massgeneralbrigham.org/en/about/newsroom/articles/most-common-cancers-in-women#:~:text=It%20may%20not%20surprise%20you,in%20women%20and%20people%20AFAB." target="_blank" rel="noreferrer noopener">the second most common cancer in women</a>. Although lung cancer overall is decreasing because of declines in tobacco use, lung cancer among people who have never smoked <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431055/#:~:text=As%20expected%2C%20the%20primary%20factor%20leading%20to,non%2Dsmokers%20has%20been%20noted%20to%20be%20increasing." target="_blank" rel="noreferrer noopener">is stable or increasing</a>, and <a href="https://www.webmd.com/lung-cancer/features/lung-cancer-women-who-never-smoked" target="_blank" rel="noreferrer noopener">two-thirds of people diagnosed with lung cancer with no smoking history are women</a>.&nbsp;



Understanding the genetics of lung cancer may help unravel some of the factors underlying those statistics. Additionally, learning more about the underlying genetics could provide researchers with more insight into the biological mechanisms of the disease, aiding in the development of improved therapies and new diagnostics.&nbsp;



The de-identified data that participants in the Lung Cancer Genetic Study consented to share isn’t limited to just genetics. Many participants also chose to provide self-reported clinical, lifestyle, and even tumor biomarker data. The study will also follow participants over time, gathering important longitudinal data to help researchers understand the progression of cancer as well as the response to treatments.&nbsp;



<h2 class="wp-block-heading">Empowering Researchers</h2>



By opening up access to qualified researchers, the collaborators aim to address significant gaps in current lung cancer research, break down institutional silos, and remove barriers to dataset access, thereby accelerating research progress.&nbsp;



&#8220;We&#8217;re delivering more than a data system — we&#8217;re enabling an entirely new model for research equity and access,&#8221; said Nadia Litterman, PhD, Director of Scientific Affairs and Partnerships at Troper Wojcicki Philanthropies.



<h2 class="wp-block-heading">Find Out More</h2>



Anyone who has been diagnosed with lung cancer can learn more and enroll in the study at<a href="http://23andme.com/lung-cancer" target="_blank" rel="noreferrer noopener"> 23andme.com/lung-cancer</a>.



Interested researchers can begin the data access request process by contacting TWP study program manager Caitlin Nichols at <a href="mailto:caitlin@twphilanthropies.org">caitlin@twphilanthropies.org</a>.&nbsp;

Illustration of lungs on a background with a larger illustration of lungs

Powerful New Tool Opens Lung Cancer Data for Research Breakthroughs

Health Huddle LIVE from New Orleans brought together top athletes, medical professionals, and community leaders for powerful conversations on health, genetics, and early detection. Hosted at Dillard University during Super Bowl Week, the event was part of 23andMe’s Community Health Huddle, featuring expert panels and free health screenings. 



Watch the Highlights: 



<figure class="wp-block-embed alignwide is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The 23andMe Health Huddle: Live from New Orleans" width="500" height="281" src="https://www.youtube.com/embed/5hOR4o5PkAU?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div></figure>



<h2 class="wp-block-heading" id="h-experts-athletes-amp-actionable-insights">Experts, Athletes &amp; Actionable Insights</h2>



Panelists included Dr. Jen Caldwell, Dr. Joel Bervell, and Dr. Mathew Knowles—a breast cancer survivor and 23andMe Global Brand Ambassador—who shared personal stories and insights on health disparities, preventive medicine, and genetic testing. They were joined by NFL Total Health Ambassadors, highlighting how genetic insights shape performance, recovery, and longevity in sports.



<h2 class="wp-block-heading" id="h-key-takeaways">Key Takeaways</h2>



<ul class="wp-block-list">
<li>Genetic Testing Saves Lives – Understanding your genetic risks enables early detection and prevention, reducing the burden of chronic diseases. </li>



<li>Your Family History is Your Health Roadmap – What runs in your family doesn’t have to define your future, but knowing your risks empowers healthier decisions. </li>



<li>Health Inequities Must Be Addressed – Underserved communities continue to lack access to vital genetic and preventive care. This must change. </li>



<li>Athletes Rely on Science to Perform &amp; Recover – The same genetic insights that help pros optimize their health can help everyone make more informed health choices.</li>
</ul>



<h2 class="wp-block-heading" id="h-beyond-the-event-driving-change">Beyond the Event: Driving Change</h2>



Health Huddle LIVE reinforced a core truth: genetic insights aren’t just about ancestry—they’re a tool for taking control of your health and advocating for better healthcare access. By bringing together medicine, sports, and community leadership, 23andMe continues to lead the movement for health equity and empowerment.



 #HealthHuddleLIVE #GeneticHealth #CommunityWellness

Inside Health Huddle LIVE: Athletes, Experts & Doctors on Longevity, Genetics & Wellness

September is Sickle Cell Awareness Month, which offers us another chance to highlight some of the work 23andMe and its collaborators have done over the years.



Earlier this month, researchers from 23andMe,<a target="_blank" href="https://www.nih.gov/" rel="noreferrer noopener"> the the National Institutes of Health</a>, and <a target="_blank" href="https://www.hopkinsmedicine.org/som/" rel="noreferrer noopener">Johns Hopkins University School of Medicine</a> published new data on the association between sickle cell trait and blood clots. The new findings highlight the importance of this ongoing research and our overall efforts to illuminate this condition.



At 23andMe, knowledge is power, and understanding risks offers people opportunities to mitigate them.&nbsp;



<h2 class="wp-block-heading" id="h-awareness-and-research">Awareness and Research</h2>



But more than that, 23andMe also offers a unique research model that allows individuals to learn about their genetic likelihood of developing a condition and participate in innovative genetic research that could potentially find new treatments.



As part of our <a href="http://www.23andme.com/sickle-cell" target="_blank" rel="noreferrer noopener">Sickle Cell Carrier Status Awareness Program</a>, 23andMe has collaborated with academics and advocacy organizations to increase <a href="https://blog.23andme.com/articles/sickle-cell-awareness-2">understanding of sickle cell</a>. In addition, we’re providing resources for those with sickle cell trait and sickle cell disease. With the help of the<a href="https://www.sicklecellga.org/" target="_blank" rel="noreferrer noopener"> Sickle Cell Foundation of Georgia, Inc. (SCFG)</a>,<a href="https://www.btsscycle.org/" target="_blank" rel="noreferrer noopener"> Breaking the SSickle Cell Cycle</a>,<a href="https://www.sc101.org/" target="_blank" rel="noreferrer noopener"> Sickle Cell 101</a>, and the<a href="https://www.msm.edu/" target="_blank" rel="noreferrer noopener"> Morehouse School of Medicine</a>, we’re working with Black communities to promote awareness. 



We are not alone in this effort. Recently, the NBA, the WNBA, and Wilson Sporting Goods began the #IBall4SickleCell social media campaign to raise awareness. The groups participating in the effort are Breaking the SSickle Cell Cycle, the American Red Cross of Tennessee, and New York Presbyterian’s Dalio Center for Health Justice. Learn more about sickle cell, the campaign, and how to help<a href="https://www.sicklecellball.com/" target="_blank" rel="noreferrer noopener"> here</a>. 



From all this work and research, we have learned much about sickle cell and the people it impacts most. However, much work is still needed to improve people’s understanding of sickle cell.



<h2 class="wp-block-heading" id="h-more-on-sickle-cell-anemia-sickle-cell-trait">More on Sickle Cell Anemia, Sickle Cell Trait</h2>



Although many people have heard of sickle cell, often they do not know the difference between sickle cell trait and sickle cell anemia.



To have sickle cell anemia, one must inherit two copies of the HbS variant in the HBB gene—one copy from each biological parent. Typical signs and symptoms include anemia, pain episodes, and frequent infection.



People with just one copy of the HbS variant are called carriers. They’re also said to have <a target="_blank" href="https://www.cdc.gov/ncbddd/sicklecell/traits.html" rel="noreferrer noopener">sickle cell trait</a>. People with sickle cell trait are not expected to have sickle cell anemia. They typically do not experience any health complications. However, in rare cases, people with the sickle cell trait may experience some health impacts. Current research, including our study, is underway to understand better and spread awareness about the complications someone with SCT may experience.



Importantly, carriers can pass their variant on to their future children. If their partner has the HbS variant or another variant in the HBB gene, there’s a 25 percent chance that each child may have sickle cell anemia or a related blood disorder.&nbsp;&nbsp;



<h2 class="wp-block-heading" id="h-23andme-s-sickle-cell-anemia-carrier-status-report">23andMe’s Sickle Cell Anemia Carrier Status Report**</h2>



23andMe’s<a target="_blank" href="https://www.23andme.com/topics/carrier/sickle-cell-anemia/" rel="noreferrer noopener"> Sickle Cell Anemia Carrier Status Report</a>, which meets FDA requirements for clinical and analytical validity, looks at the HbS variant in the HBB gene linked to sickle cell anemia.



Sickle cell anemia is the most severe form of sickle cell disease. Three hundred million people worldwide and one in 13 Black and African Americans in the United States have sickle cell trait, making them carriers for sickle cell anemia.



In addition to informing people if they have one copy of the HbS variant and are carriers for sickle cell anemia, <a href="https://blog.23andme.com/articles/23andme-updates-carrier-status-report-on-sickle-cell-anemia">23andMe’s report </a>can also tell individuals if they have two copies of the tested variant and if they are at risk of developing symptoms. However, the report does not describe one’s overall risk of developing symptoms. 



Because the HbS variant is more common in certain populations, the Sickle Cell Anemia report is most relevant to people of African, Middle Eastern, and South Asian descent, as well as people from the Caribbean, the Mediterranean, and parts of Central and South America.



23andMe Health + Ancestry Service customers and 23andMe+ Premium members can see their <a target="_blank" href="https://you.23andme.com/reports/carrier.sickle_cell_anemia/" rel="noreferrer noopener">Sickle Cell Anemia report here</a>.&nbsp;



Not yet a customer? Learn more about <a target="_blank" href="https://www.23andme.com/compare-dna-tests/?_gl=1*11ns9j4*_ga*OTk4NDAyMjA3LjE3MTgzODA2MTg.*_ga_G330GF3ZFF*MTcyNTQxNDcyOS4xNjQuMS4xNzI1NDE0Nzk4LjAuMC4w" rel="noreferrer noopener">all that 23andMe offers here</a>.



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading" id="h-note">Note:</h2>



**The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults to report carrier status and reporting and interpreting genetic health risks. The relevance of each report may vary based on ethnicity. Our carrier status reports can be used to determine carrier status but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. We provide a single report for certain conditions that includes information on carrier status and genetic health risk. For important information and limitations regarding other genetic health risk reports and carrier status reports, click <a target="_blank" href="https://www.23andme.com/test-info/" rel="noreferrer noopener">here</a>.

An illustration for 23andMe's Sickle Cell Carrier Statues Awareness Program.

Learn More About Our Research and Collaborations During Sickle Cell Awareness Month

Editor&#8217;s note 7/8/2024: This post has been updated since 2020. In addition, We do not support uploading DNA data obtained from other testing services to 23andMe. This article explains the risks of uploading your DNA data to third party services.
With all of <a class="waffle-rich-text-link" href="https://www.23andme.com/compare-dna-tests/">23andMe&#8217;s services</a>, you’re in charge of your genetic data. That means we let you decide what information you want to learn and what information you want to share. However, you need to be informed about the risks of sharing your genetic data with other services. This includes understanding the implications if you decide to upload DNA to 23andMe or any third-party service.
After receiving <a class="waffle-rich-text-link" href="https://www.23andme.com/dna-reports-list/">personalized genetic reports</a> from 23andMe, customers can choose to download their raw DNA data. Some customers may do this to upload their data to third-party services, which offer to interpret their raw DNA data to find new genetic relatives or get additional genetic reports. However, 23andMe cannot vouch for the scientific validity or accuracy, or clarity in communication of results of any such third-party services. In fact, only 23andMe offers a consumer genetic test with health reports that have FDA&#8217;s independent assurance of validity and clear results (without requiring a prescription).
Beyond concerns about scientific validity, uploading your raw DNA data to a third-party service can also put <a href="https://www.23andme.com/privacy/">your data privacy</a> at risk. In part, this is why 23andMe provides important warnings to its customers before they choose to download.
<h2>What are some of the risks of uploading your DNA data to a third-party website? </h2>
<div id="attachment_27862" style="width: 310px" class="wp-caption alignright"><a href="https://blog.23andme.com/articles/how-to-be-careful-with-your-raw-dna-data/what-is-dna-upload" rel="attachment wp-att-27862"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-27862" class="size-medium wp-image-27862" src="http://35.88.189.111/wp-content/uploads/2020/01/What-is-DNA-Upload-300x128.jpg" alt="An illustration of the steps for downloading data." width="300" height="128" srcset="https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2020/01/What-is-DNA-Upload-300x128.jpg 300w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2020/01/What-is-DNA-Upload.jpg 512w" sizes="auto, (max-width: 300px) 100vw, 300px" /></a>Most consumer genetics companies, including 23andMe, allow you to download your own raw DNA data. At that point, the customer is free to do what they like with their raw DNA data, such as deciding to upload that raw DNA data to third-party services.</div>
At 23andMe, we’re clear with our users about the risks of using third-party services that provide additional health, wellness or trait insights. This is because only select genotype data used specifically in our Health reports have been individually validated for accuracy. While the rest of your data has undergone a general quality review, it has not been validated to the extent of the data underlying our official 23andMe reports. As a result, raw DNA data should not be used for medical purposes and we do not recommend the use of third-party services that claim to interpret raw DNA data to provide health information.
Consumers also cite concerns about law enforcement uploading crime-scene DNA data to third-party services to crack a cold case. Simply put, uploading crime-scene DNA data into the 23andMe environment is not possible because we do not support the upload of DNA data that has been processed by a third-party laboratory.
Further, 23andMe’s <a href="https://www.23andme.com/transparency-report/">Transparency Report</a> details our policy against releasing customer’s individual DNA data to any third party &#8211; including law enforcement &#8211; without receiving the customer’s explicit consent, unless required by law.
However, this concern about law enforcement upload of crime scene DNA data is a real one that we warn customers about should they choose to upload their DNA data to other third party platforms, including public genealogy services or other third party services that facilitate DNA data upload.
But there’s another form of vulnerability that’s less well-understood: Within databases that allow for raw DNA data uploads with access to relative matching features, people with malicious intent can upload real or fake “<a href="https://en.wikipedia.org/wiki/Trojan_horse_(computing)">Trojan Horse</a>” genetic profiles for access to your personal identifying information. They could even infer your specific DNA variants—such as information about any disease risk variants you might carry. This is one reason why we don&#8217;t support uploading DNA to 23andMe.
<h2>How can that happen?</h2>
<ul>
<li>Many relative-matching services allow you to see the exact section or sections of DNA you share with each relative.*</li>
<li>If uploading DNA data is allowed, it means you no longer know for sure that your relative’s profile is actually controlled by your relative, and a malicious actor could upload real or fake DNA data to deduce information about you based on sections of matching DNA, including any disease risk variants you might have.</li>
<li>Even if shared segments aren’t shown, there are still ways that people with malicious intent can deduce some of your DNA variants.</li>
</ul>
<img loading="lazy" decoding="async" class="size-medium wp-image-27863 alignright" src="https://blog-api.23andme.com/wp-content/uploads/2020/01/How-Uploading-Creates-Risk-300x202.jpg" alt="" width="300" height="202" srcset="https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2020/01/How-Uploading-Creates-Risk-300x202.jpg 300w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2020/01/How-Uploading-Creates-Risk.jpg 512w" sizes="auto, (max-width: 300px) 100vw, 300px" />
This vulnerability was recently described in two reports: one at the University of Washington and another at the University of California, Davis. The authors of these reports explain several ways an “adversary” can deduce people&#8217;s genotypes “either at key positions or at many sites genome-wide” in databases that allow DNA data uploads with relative matching. This highlights the risks associated with uploading DNA to 23andMe or similar services.
Both reports outline specific ways for services to mitigate risk, such as limiting the information displayed in relative-matching features.
While these practices may reduce risk, we believe the simplest and most effective defense is to not allow individuals genotyped through other testing services to upload their DNA data to 23andMe for the purpose of discovering genetic relatives.
In the past, 23andMe has allowed DNA uploads from other consumer genetic testing services in very specific circumstances. Specifically, on DNA Day in April 2018, 23andMe allowed individuals who tested at other companies to upload their results to access a subset of our trait reports, but 23andMe has not enabled the discovery of new relatives for these accounts.
<h2>How does 23andMe ensure that only real, consenting individuals participate in our service? </h2>
In a word, spit.
When you spit into the tube, you’re embarking on the adventure of a lifetime. You’re also trusting 23andMe with some of your most personal information.
Requiring a saliva sample is how 23andMe is able to verify that you’re a real person who chose to participate in the service. While it might be easy to upload fake DNA data, it’s another matter entirely to fake a spit sample, which requires filling a tube with more than two milliliters of spit. It’s how you know that “Linda-your-4th-cousin-who-you-didn’t-know-existed” is a real person who chose to do 23andMe. Linda had to spit in a tube, too.
<h2>What are some key questions you should ask?</h2>
When considering whether or not to upload your raw DNA data to another website, we encourage you to familiarize yourself with their privacy and security policies before you upload your raw DNA data.
Make sure to consider the following questions:
<ol>
<li>Before you upload your DNA data, ask yourself: do I really need to do this? Am I willing to risk the security and privacy of my DNA data by uploading it to a third-party service?</li>
<li>Do your research! Does the third-party service have a track record of strong privacy and data security?</li>
<li>How will the third-party service use your information?  How can your information be further shared with other third parties?</li>
<li>If you are not interested in discovering new relatives but you want additional DNA insights, does the other service explicitly exclude features relating to discovering genetic relatives?</li>
</ol>
An earlier article detailing our stance on protecting customers’ data is available <a href="https://blog.23andme.com/news/our-stance-on-protecting-customers-data/">here</a>. 
<h2>Learn More</h2>
Find out if your <a href="https://www.23andme.com/test-info/genetic-health/">genetics</a> might Increase your risk for any health conditions with 23andMe.
You can also Learn more about common risks associated with uploading raw DNA online and how to protect your DNA information.
*By default, 23andMe does not display your ancestry information or DNA segment information to relatives or connections until you decide to share it with them.

Can You Upload DNA Data to 23andMe? 

Today is DNA Day, and while every day at 23andMe is about DNA, this one is extra special because it allows everyone to delight in the power of DNA.



Whether you are a 23andMe customer or just DNA curious, there is a lot you can do if you’d like to start or deepen your genetic journey and take action to participate in the new genomic age.



We’ll get to that, but first, take a moment to learn —or refresh your knowledge — about what we’re celebrating.



<h2 class="wp-block-heading" id="h-a-double-helix-celebration">A Double Helix Celebration</h2>



<a href="https://www.genome.gov/dna-day">DNA Day</a> commemorates the anniversary of the 1953 discovery of the double helix structure of DNA and the 2003 completion of the human genome project that led to the sequencing of the human genome for the first time. That code represents the building blocks of life, and it gives us access to information that has already led to medical and scientific breakthroughs, as well as an understanding of the human story.



23andMe was founded in 2006, not long after the publication of the mapping of the human genome. Our mission then and now is to help people access, understand, and benefit from the human genome.&nbsp;



Not too long ago, 23andMe surpassed 15 million genotyped customers, each of whom chose to begin their genetic journey with us. We’d like to invite you along as well, or if you’re already a customer, we’d like to share with you how to go a little further on this journey.



<h2 class="wp-block-heading" id="h-first-steps">First Steps</h2>



If you’re not yet a customer, your first step could be to spit in a tube provided in one of our test kits and send it to our lab. At the lab, technicians extract DNA from your saliva, which is placed on a genotyping chip.



Here’s <a href="https://www.youtube.com/watch?v=BtxX_3nVDao">a little video</a> about the different services we offer customers and what they can tell you about your health, traits, and ancestry.



Of course, if you don’t want to use 23andMe or don’t want to use a genetic test, there are plenty of great and free options for learning more about genetics. One of our go-to resources is the <a href="https://www.genome.gov/about-genomics">National Human Genome Research Institute</a>, but many other options exist.



<h2 class="wp-block-heading" id="h-open-and-explore-your-reports">Open and Explore Your Reports</h2>



Like with any exploration, you don’t know what you might find in using 23andMe that could draw you deeper into your DNA exploration.



Customers might want to learn more about their health, find DNA relatives, or learn about their genetic ancestry. Some people are just curious and want to geek out on genetics.&nbsp;



If you’ve taken that first step and tested, the next step is to open your reports. Some Genetic Health Risk Reports*—such as those on Late-Onset Alzheimer’s Disease, BRCA1/BRCA2 (Selected Variants), and Parkinson’s Disease, for instance—require an additional opt-in before opening. But whatever reports you’re looking at, we have tutorials on navigating them and where to start.



Our <a href="https://www.23andme.com/dna-ancestry/">Ancestry Service</a> has the most comprehensive ancestry breakdown on the market; it now includes more than 3000 geographic regions, an automatic family tree builder, and more than 30 trait reports. As 23andMe grows, so does our ability to improve the granularity and specificity of the regions we offer in our ancestry report. For instance, we added 36 new Genetic Groups in France and Belgium.&nbsp;



23andMe’s <a href="https://www.23andme.com/dna-health-ancestry/">Health + Ancestry Service</a> includes everything you get in the Ancestry Service plus health predisposition reports (including FDA-authorized reports), wellness reports, carrier status reports, and a family health history tree feature. In all, the service includes more than 150 personalized reports.



The 23andMe+ Premium membership includes everything in the Health + Ancestry Service plus more than 30 PRS reports, including reports on three of the most common forms of cancer and reports on heart health and mental health conditions like anxiety and depression. In addition, the service includes FDA-authorized reports on how your genetics may impact the way you process certain types of medications.** 23andMe+ Premium also includes tools and features such as <a href="https://blog.23andme.com/articles/stay-on-track-with-23andme-health-tracks">Health Tracks</a>SM and <a href="https://blog.23andme.com/articles/a-health-action-plan-for-you">Health Action Plan</a> to help you get even more personalized recommendations. Most recently, we’ve added a new ancestry feature called <a href="https://blog.23andme.com/articles/23andmes-historic-matches">Historical Matches</a>SM that helps determine whether you connect to one or more of 335 historical people across the globe.&nbsp;



For those who want our most advanced and comprehensive health membership, we offer <a href="https://www.23andme.com/total-health/">23andMe+ Total Health</a>***, which includes next-generation sequencing that detects 200x more disease-causing genetic variants*. This new membership offers more than 190 genetic reports from 23andMe+ Premium, along with clinician-ordered exome sequencing to help identify disease risks and biannual blood testing with advanced cardiometabolic biomarkers. You&#8217;ll have direct access to clinicians trained in genetics-informed care to receive a personalized health plan tailored to you



Whatever services you’re using with 23andMe, we offer a guide to <a href="https://www.23andme.com/compare-dna-tests/">get started with your reports</a>.



<h2 class="wp-block-heading" id="h-participate-in-research">Participate in Research</h2>



What is something in you, something in your DNA, that could help scientists better understand a disease or develop a new treatment or cure?&nbsp;



One of the many innovations 23andMe pioneered is our research model, which allows people to consent to participate in research. The guiding principle for 23andMe is transparency and choice. It’s a choice whether someone wants to access their genetic information, and 23andMe also gives our customers a choice about whether they want to participate in research. More than 80 percent of 23andMe customers actively consent to participate in research.&nbsp;



Our research database, which contains aggregated de-identified genetic and phenotypic data, is by far the largest research database of its kind.&nbsp;



It’s helped not just our scientists but academic and institutional researchers with whom we’ve collaborated on more than <a href="https://research.23andme.com/publications/#publications">250 publications</a> on neurological conditions, cancers, and rare diseases. There are also ongoing research studies for <a href="https://www.23andme.com/PD/">Parkinson’s Disease,</a> <a href="https://www.23andme.com/genetic-insights-into-colorectal-cancer-black-community/">Colorectal Cancer within the Black Community</a>, and <a href="https://www.23andme.com/sickle-cell/">Sickle Cell</a>. And we continue to work on other conditions, including <a href="https://www.23andme.com/depression-bipolar/">depression and bipolar disorder</a>, <a href="https://www.23andme.com/sarcoidosis-representation/">sarcoidosis</a>, and <a href="https://you.23andme.com/covid19-study/">COVID</a>.&nbsp;



Another aspect of this work is ensuring that our research is more representative and thus benefits people of all backgrounds. Unfortunately, much of genetic research to date lacks diversity, which has meant that people of non-European backgrounds often do not benefit from those insights. 23andMe is trying to change that. Our Black Representation in Genomic Research study, for instance, has made great strides at engaging with communities that have historically been left out of research.&nbsp;



You can also help. If you’re a customer of 23andMe, you can consent to participate in research at any time through your Account Settings; if you’re not, you can seek out opportunities to participate in research through the <a href="https://allofus.nih.gov/">National Institutes of Health’s All of Us</a> effort, for example, or the Veteran’s Administration <a href="https://www.research.va.gov/mvp/">Million Veterans Program</a>.



<h2 class="wp-block-heading" id="h-share-your-story">Share Your Story</h2>



It’s always been heartening for us at 23andMe to hear from our customers and those who participate in our research about how launching their DNA journey has impacted them.&nbsp;



Whether they’ve learned more about their <a href="https://blog.23andme.com/articles/23andme-connects-living-family-to-enslaved-african-american-from-historic-site">family’s ancestral journey</a>, discovered <a href="https://www.youtube.com/watch?v=hbWirWghCJA">life-saving information</a> about family members, or joined with others to <a href="https://www.youtube.com/watch?v=2JzErEQFPIU">participate in crucial genetic research</a>, their stories inspire us all.&nbsp;



If you have a story to share, <a href="https://www.23andme.com/stories/#submit">we’d love to hear it</a>.



<hr class="wp-block-separator has-alpha-channel-opacity"/>



*23andMe health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports that are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. 



Warnings &amp; Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting 44 variants in the BRCA1 and BRCA2 genes. The report describes if a person&#8217;s genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers. The variants included in this report do not represent the majority of the BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18 and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. For important information and limitations regarding each genetic health risk report, visit <a href="https://www.23andme.com/test-info/">23andme.com/test-info/</a>. 



**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene, and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with the metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit <a href="http://23andme.com/test-info/pharmacogenetics/">23andme.com/test-info/pharmacogenetics/</a> 



***Total Health is not available to residents of HI, NJ, NY, OK, RI and US territories. Not currently available to existing 23andMe customers. <a href="https://www.23andme.com/total-health/#sign-up">Sign up</a> to be the first to know when it’s available.



Exome Sequencing and blood testing services are available to eligible customers upon completion of the intake questionnaire that must be reviewed, approved and ordered by a third-party clinician. Exome Sequencing is analyzed by a CLIA- and CAP-accredited laboratory. Blood testing is completed by Quest Diagnostics. All telehealth services are provided in accordance with the Telehealth Terms and Consent Telehealth.



‡Our genotyping product detects 250 health-related variants in our Carrier Status and Genetic Health Risk reports. The Exome Sequencing reports detect 50,000+ hereditary disease-causing variants.&nbsp;

Happy DNA Day 2024

Cancer casts its shadow on almost all of us. Whether we&#8217;re facing our own diagnosis or that of a spouse, a parent, a child, a friend, or another loved one, we can muster the courage we need in those moments by knowing we are not alone.



<h2 class="wp-block-heading" id="h-beat-cancer">Beat Cancer</h2>



We at 23andMe are encouraged by the White House’s recent designation of April as National Cancer Prevention and Early Detection Month to rally support for those affected and their families and highlight the importance of prevention and screening.



But beyond simply naming the month, this is part of a collective effort to raise awareness that includes <a href="https://www.preventcancer.org/wp-content/uploads/2024/03/2024_White_House_partner_letter_Cancer_Prevention_Early_Detection_FINAL.pdf">support from 84 non-profit and patient advocacy organizations</a>. Each group focuses on expanding cancer screening, research, and treatments. 



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="1024" src="http://35.88.189.111/wp-content/uploads/2024/04/Get-your-green-on-1024x1024.png" alt="" class="wp-image-32772" srcset="https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-1024x1024.png 1024w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-150x150.png 150w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-300x300.png 300w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-768x768.png 768w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-880x880.png 880w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-1180x1180.png 1180w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-271x271.png 271w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-372x372.png 372w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-574x574.png 574w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on-980x980.png 980w, https://blog.pub.us-west-2.prd.23andme.us/wp-content/uploads/2024/04/Get-your-green-on.png 1200w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">23andMe Employees wearing green in support of National Cancer Prevention and Early Detection Month.</figcaption></figure>



<h2 class="wp-block-heading" id="h-progress">Progress</h2>



So much progress has been made already — <a href="https://www.cdc.gov/hpv/parents/vaccine/six-reasons.html">vaccines against human papillomavirus</a> promise to slash the rates of cervical cancer; cancer screening has <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405449/">saved millions of lives</a> in the last three decades; new <a href="https://www.cancer.gov/news-events/press-releases/2020/lung-cancer-treatments-mortality-drop">treatments for lung cancer</a> have reduced mortality rates; and immunotherapies such as <a href="https://www.cancer.gov/about-cancer/treatment/research/car-t-cells">CAR-T cell therapy</a> have improved outcomes for many types of cancer.



However, much more needs to be done. Every year, more than 1.8 million people in the United States are <a href="https://www.cancer.gov/about-cancer/understanding/statistics">diagnosed with cancer</a>, and more than 600,000 people die each year, making it the <a href="https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm">second leading cause of death</a> behind heart disease.&nbsp;



Every cancer is different, but early detection and treatment offer the best outcomes for all cancers. Improved awareness about cancer screening — regular mammograms and colorectal cancer screening, for instance — can go a long way toward early detection.&nbsp;



Knowing one&#8217;s risk by learning about one&#8217;s family cancer history, or through genetic testing, or simply through identifying risk factors in one&#8217;s life can help identify those at higher risk and direct them toward preventive care or enhanced screening.



<h2 class="wp-block-heading" id="h-the-power-of-knowing">The Power of Knowing</h2>



23andMe wants to show our support for this new effort but also share a little about how we are raising awareness about cancer, alerting people of their potential risk for different forms of cancer, and adding to the growing body of research into cancer to potentially identify causes and cures.



In the coming weeks, we’ll share more about what 23andMe has done and is doing to help people better understand their genetic risk and family cancer history and how that knowledge is a formidable tool for cancer prevention.



<h2 class="wp-block-heading" id="h-find-out-more">Find Out More</h2>



Learn more about cancer prevention and screening from the <a href="https://www.preventcancer.org/cancer-prevention-early-detection-month/">Prevent Cancer Foundation</a>. You can explore more about all that 23andMe has to offer <a href="https://www.23andme.com/compare-dna-tests/">here</a>.

A photo of a doctor showing a patient information on a digital tablet.

Improving Cancer Outcomes Through Early Diagnosis and Treatment

Fundamental, common humanity unites every person on the planet: DNA. Some use race and biology to explain what are, in reality, social and cultural differences between people. It’s a fact that we humans are genetically 99.5 percent identical.&nbsp;



23andMe is a brand that leads with science. We fundamentally believe that we are more alike than we are different. Understanding that ridding ourselves of socially constructed ‘isms’ — like racism or classism —frees everyone. When we step out of systems of “us” vs “them” and bear witness to the oppression of people everywhere, humanity takes center stage.&nbsp;



Isabel Wilkerson’s biographical New York Times best-selling book, Caste, inspired Ava DuVernay’s new film ORIGIN. As with the book, DuVernay’s moving film adaptation — starring Aunjanue Ellis-Taylor as Wilkerson — analyzes discrimination and the connections between American racism, Nazi persecution of Jews, and India&#8217;s caste system.&nbsp;



It is the 0.5 percent that makes us each genetically different from one another and has also bred hatred across the world.



23andMe believes that focusing on all that we share as humans, and celebrating what makes us unique, could bring the world together. So for the next 23 days of January, 23andMe will donate 100 seats daily, to the <a href="https://www.seat16.com/">Seat16 program</a> which has a goal of getting 10,000 young people around the country to see the new film, ORIGIN.



Everyone deserves a place in this world and we believe in focusing on the things we share in common. Above all else, we want the world to remember that we are all 100 percent human.



ORIGIN will be in select theaters starting on January 19, 2024. 23andMe CEO and Co-founder Anne Wojcicki helped produce the film. You can see the ORIGIN film trailer <a href="https://www.youtube.com/watch?v=pAweg5PaMuw">here.</a> 



#100PercentHuman <a href="https://www.instagram.com/p/C1VAohGvlEW/?img_index=2">#ORIGINFilm</a> <a href="https://www.instagram.com/explore/tags/seat16/">#Seat16</a> <a href="https://www.instagram.com/explore/tags/23andme/">#23andMe</a> <a href="https://www.instagram.com/explore/tags/unityindiversity/">#UnityInDiversity</a>

Origin and Our Common Humanity

Sit back and listen to 23andMe CEO and Co-Founder <a href="https://blog.23andme.com/articles/23andmes-anne-wojcicki-among-the-best-ceos-for-women">Anne Wojcicki, </a>along with 23andMe board member and founder of 23andMe Therapeutics division <a href="https://blog.23andme.com/articles/richard-scheller-named-to-national-academy-of-medicine">Richard Scheller</a>, speak to Roelof Botha of Sequoia Capital about the company&#8217;s critical moments in history.



Botha, who is also on the 23andMe Board of Directors, discusses how the company weathered early criticism, even at its founding in 2006, from the 2013 FDA letter that ordered 23andMe to stop selling health testing products to customers to downturns in consumer interest.



The episode is part of a series called <a href="https://www.cruciblemoments.com/episodes/23andme" target="_blank" rel="noreferrer noopener">Crucible Moments,</a> produced by Sequoia Capital. In this series, Roelof explores moments in every start-up business journey in which a company can succeed or fail. How a company responds often defines its future.



Listen to <a href="https://www.cruciblemoments.com/episodes/23andme">Anne&#8217;s Crucible Moments</a> and learn a little about <a href="https://blog.23andme.com/articles/23andme-turns-16">23andMe&#8217;s history</a>.

Crucible Moments in 23andMe’s History

Since 2019, 23andMe customers have had the option to utilize authenticator app 2-factor authentication, which adds an extra layer of security to their account. Starting today, we are requiring all customers use a second step of verification to sign into their account.&nbsp;



<h6 class="wp-block-heading" id="h-what-is-2-step-verification">What is 2-Step Verification?</h6>



2-step verification (2SV), also referred to as 2-factor authentication, requires customers to provide two distinct steps to sign in before accessing their accounts. In combination with a username and password, customers will be asked for a verification code. 



Depending on what method customers choose to use, that code will either be generated by an authenticator app, or sent to their email if they use email 2-step verification. This code is another way to verify the customer’s identity before accessing their account.



<h6 class="wp-block-heading" id="h-setting-up-2-step-verification">Setting Up 2-Step Verification</h6>



New customers will be automatically enrolled in email 2SV when they create their account. Existing customers who do not already use an authenticator app will also be automatically enrolled in email 2SV, and will receive an email containing their verification code at their next sign-in. 



Existing customers who already use an authenticator app, can continue to use that option. New customers who want to use an authenticator app, such as Google Authenticator™ mobile app, instead of email 2SV, can set up the authenticator app using the instructions found <a href="https://customercare.23andme.com/hc/en-us/articles/360034119874-Adding-2-Step-Verification-to-Your-23andMe-Account">here</a>. 



<h6 class="wp-block-heading" id="h-questions">Questions?</h6>



As always, customers can work with our <a href="https://customercare.23andme.com/hc/en-us/">Customer Care team</a> if they have questions about using this added security step.



 This new security update is part of our ongoing commitment to keep customer data safe and secure. It’s another line of defense to protect their data. We encourage all of our customers to review our <a href="https://customercare.23andme.com/hc/en-us/articles/360062175913-Privacy-and-Security-Help-Center">Privacy and Security Checkup</a> page, where they will find additional information on how to keep their accounts secure.

An image of a lock a computer, DNA and a mobile phone representing security protections.

News